No australia wouldn't be bound by the US label and the Australian label isn't known yet because its not approved. However, unless you know something that I don't I don't see a reason why a label in countries that approve the drug going forward will differ in a meangingful way from the existing label absent any new clinical data.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.